← Open Payments lookup

GRACE JABLONSKI: Open Payments

NPI 1467201350 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,357 in 61 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $846 · 2025 $1,357

Food & beverage: $1,357
CompanyPaymentsAmount
ABBVIE INC.18$340
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$220
Takeda Pharmaceuticals U.S.A., Inc.9$215
Ardelyx, Inc.9$196
Gilead Sciences, Inc.7$160
Madrigal Pharmaceuticals2$52
Aimmune Therapeutics, Inc.2$49
Phathom Pharmaceuticals, Inc.1$35
Lilly USA, LLC1$29
Novo Nordisk Inc1$23

Products named: XIFAXAN, IBSRELA, ENTYVIO, LINZESS, RINVOQ, SKYRIZI, REZDIFFRA, GATTEX.

Industry payments across RI — which companies pay providers there.